Because of our novel finding that cyclin D1 promotes pyrimidine synthesis, we wondered whether combined inhibition of its main kinase partner (Cdk4) along with the downstream pyrimidine synthesis enzyme dihydroorotate dehydrogenase (DHODH) (Fig. 6B) would synergistically block cancer cell growth. Here, CDK4 is linked to cancer.